Unknown affiliation
Verified email at
Cited by
Cited by
A communication strategy and brochure for relatives of patients dying in the ICU
A Lautrette, M Darmon, B Megarbane, LM Joly, S Chevret, C Adrie, ...
New England Journal of Medicine 356 (5), 469-478, 2007
High versus low blood-pressure target in patients with septic shock
P Asfar, F Meziani, JF Hamel, F Grelon, B Megarbane, N Anguel, JP Mira, ...
New England Journal of Medicine 370 (17), 1583-1593, 2014
Initiation strategies for renal-replacement therapy in the intensive care unit
S Gaudry, D Hajage, F Schortgen, L Martin-Lefevre, B Pons, E Boulet, ...
New England Journal of Medicine 375 (2), 122-133, 2016
Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial
O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ...
JAMA internal medicine 181 (1), 32-40, 2021
Hydrocortisone plus fludrocortisone for adults with septic shock
D Annane, A Renault, C Brun-Buisson, B Megarbane, JP Quenot, S Siami, ...
New England Journal of Medicine 378 (9), 809-818, 2018
Intravascular complications of central venous catheterization by insertion site
JJ Parienti, N Mongardon, B Mégarbane, JP Mira, P Kalfon, A Gros, ...
New England Journal of Medicine 373 (13), 1220-1229, 2015
Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial
P Jabre, X Combes, F Lapostolle, M Dhaouadi, A Ricard-Hibon, B Vivien, ...
The Lancet 374 (9686), 293-300, 2009
Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial
JJ Parienti, M Thirion, B Mégarbane, B Souweine, A Ouchikhe, A Polito, ...
Jama 299 (20), 2413-2422, 2008
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
A Alanio, S Dellière, S Fodil, S Bretagne, B Mégarbane
The Lancet Respiratory Medicine 8 (6), e48-e49, 2020
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
Symptoms of anxiety, depression, and peritraumatic dissociation in critical care clinicians managing patients with COVID-19. A cross-sectional study
E Azoulay, A Cariou, F Bruneel, A Demoule, A Kouatchet, D Reuter, ...
American journal of respiratory and critical care medicine 202 (10), 1388-1398, 2020
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
A Rouzé, I Martin-Loeches, P Povoa, D Makris, A Artigas, M Bouchereau, ...
Intensive care medicine 47, 188-198, 2021
Synthetic cathinones: a new public health problem
L Karila, B Megarbane, O Cottencin, M Lejoyeux
Current neuropharmacology 13 (1), 12-20, 2015
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ...
The Lancet Respiratory Medicine 9 (3), 295-304, 2021
Position paper update: gastric lavage for gastrointestinal decontamination
BE Benson, K Hoppu, WG Troutman, R Bedry, A Erdman, J Höjer, ...
Clinical toxicology 51 (3), 140-146, 2013
Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest
B Mégarbane, P Leprince, N Deye, D Résière, G Guerrier, S Rettab, ...
Intensive care medicine 33, 758-764, 2007
Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning
FJ Baud, SW Borron, B Mégarbane, H Trout, F Lapostolle, E Vicaut, ...
Critical care medicine 30 (9), 2044-2050, 2002
Critical care toxicology
J Brent, K Burkhart, P Dargan, B Hatten, B Megarbane, R Palmer
Springer, 2016
Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial
P Asfar, F Schortgen, J Boisramé-Helms, J Charpentier, E Guérot, ...
The Lancet Respiratory Medicine 5 (3), 180-190, 2017
The tyrosine kinase substrate eps15 is constitutively associated with the plasma membrane adaptor AP-2.
A Benmerah, J Gagnon, B Bègue, B Mégarbané, A Dautry-Varsat, ...
The Journal of cell biology 131 (6), 1831-1838, 1995
The system can't perform the operation now. Try again later.
Articles 1–20